SA
VRTX icon

Shilanski & Associates’s Vertex Pharmaceuticals VRTX Stock Holding History

Shilanski & Associates’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,983
Closed -$812K – 104
2020
Q3 		$812K Buy
+2,983
New +$812K 0.55% 54